Title: 2016 ACVIM Forum Research Abstract Program Document date: 2016_5_31
ID: 2y1y8jpx_813
Snippet: The treatment*sampling hour interaction affected abomasal outflow pH for both a single dose and multiple doses of famotidine (P < 0.001). A single dose of intravenous famotidine resulted in a significant increase of abomasal outflow pH as compared to the control group for 4 hours after administration (P < 0.05). When administered every 8 hours, the abomasal outflow pH of the famotidine treated group was greater than the control group for 4 hours .....
Document: The treatment*sampling hour interaction affected abomasal outflow pH for both a single dose and multiple doses of famotidine (P < 0.001). A single dose of intravenous famotidine resulted in a significant increase of abomasal outflow pH as compared to the control group for 4 hours after administration (P < 0.05). When administered every 8 hours, the abomasal outflow pH of the famotidine treated group was greater than the control group for 4 hours after the first dose (P < 0.05), 2 hours after the second dose, and 1 hour after the third dose (P < 0.05). Pharmacokinetic analysis demonstrated that famotidine had a terminal half-life of 3.33 (3.21 -3.54; median and range) hours, a volume of distribution of 0.042 (0.014 -1.89) L/kg and a clearance of 1.26 (0.625 -11.5) mL/min/kg.
Search related documents:
Co phrase search for related documents- abomasal outflow and intravenous famotidine single dose: 1
- abomasal outflow and pharmacokinetic analysis: 1
- abomasal outflow and single dose: 1, 2
- control group and distribution volume: 1, 2, 3, 4, 5, 6, 7
- control group and half life: 1, 2, 3, 4, 5
- control group and multiple dose: 1, 2, 3
- control group and second dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46
- control group and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- control group and single dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
- control group and treat group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- control group compare and distribution volume: 1
- control group compare and significant increase: 1
- distribution volume and half life: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
Co phrase search for related documents, hyperlinks ordered by date